Completed (17)

Terminated (8)

Active, not recruiting (7)

Recruiting (5)

Unknown status (5)

phase 3 (22)

phase 2 (9)

phase 1/phase 2 (5)

phase 1 (2)

phase 4 (1)

AstraZeneca (1)

Eli Lilly and Company (1)

Merck KGaA, Darmstadt, Germany (1)

National Science Council, Taiwan (1)

Singapore Clinical Research Institute (1)

drug (38)

biological (4)

other (3)

procedure (1)

Industry (37)

Other (5)

Interventional (39)

Observational (2)

Observational [Patient Registry] (1)

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 42

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS